Impact of prophylactic mupirocin for radical esophagectomy

Area of Science:

• Surgical Oncology
• Infectious Disease Prevention
• Clinical Pharmacology

Background:

• Nosocomial Staphylococcus aureus infections are a concern, particularly in surgical patients.
• Preoperative intranasal mupirocin is known to reduce infections in S. aureus carriers.
• Its efficacy in preventing postoperative infections, especially MRSA, after major surgery remains less clear.

Purpose of the Study:

• To evaluate the effectiveness of preoperative intranasal mupirocin in reducing postoperative MRSA infections and pneumonia.
• To identify patient subgroups who benefit from prophylactic mupirocin use.
• To assess the impact of mupirocin on postoperative hospital stay following esophagectomy.

Main Methods:

• A prospective study involving 96 patients undergoing elective radical esophagectomy.
• Patients received either mupirocin calcium ointment or a placebo (not explicitly stated, but implied by comparison) preoperatively.
• Univariate and multivariate analyses were used to assess outcomes: MRSA infection, pneumonia, and length of hospital stay.

Main Results:

• Univariate analysis showed mupirocin significantly reduced MRSA infection, postoperative pneumonia, and hospital stay.
• Multivariate analysis confirmed mupirocin's significant association with reduced MRSA infection and pneumonia.
• No significant association was found between mupirocin and reduced length of hospital stay in multivariate analysis.

Conclusions:

• Preoperative prophylactic mupirocin administration is warranted for patients undergoing radical esophagectomy.
• This intervention effectively reduces postoperative infectious complications, specifically MRSA infections and pneumonia.
• Routine use of mupirocin is considered reasonable for this high-risk surgical procedure.